TEVA
Teva Pharmaceutical Industries Limited
The mark consists of a light green design that begins at the bottom left hand corner and rises up to the upper right hand corner. This light green continues in a straight light across the top. There are 2 darker green half circles at the bottom right hand corner that when they intersect make a dark green. In the dark green intersection at the bottom right hand corner is the word "teva" in lower case white letters. The "v" in the word "teva" is formed by 2 leaf shapes. The color white also appears in the rectangle created by the gray outlining the entire mark. The entire mark is outlined by a thin gray line.
Mark For: TEVA™ trademark registration is intended to cover the categories of
>The color(s) dark green, light green, white and gray is/are claimed as a feature of the mark. The mark consists of a light green design that begins at the bottom left hand corner and rises up to the upper right hand corner. This light green continues in a straight light across the top. There are 2 darker green half circles at the bottom right hand corner that when they intersect make a dark green. In the dark green intersection at the bottom right hand corner is the word "teva" in lower case white letters. The "v" in the word "teva" is formed by 2 leaf shapes. The color white also appears in the rectangle created by the gray outlining the entire mark. The entire mark is outlined by a thin gray line.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87352574 |
| Mark Literal Elements | TEVA |
| Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
| Mark Type | TRADEMARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2018-02-20 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Laurence Rickles |
| Law Office Assigned | L10 |
| Employee Name | MICHELI, ANGELA M |
Timeline
| 2017-02-28 | Application Filed |
| 2017-12-26 | Published |
| 2017-12-26 | Published for Opposition |
| 2018-02-20 | Location: INTENT TO USE SECTION |
| 2019-08-13 | Status: Live/Pending |
| 2019-08-15 | Transaction Date |
| 2020-08-21 | Status: A fifth request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Teva Pharmaceutical Industries Limited |
| Address | Science Based Industries Campus Har Hotzvim Jerusalem ISRAEL 91010 |
| Legal Entity Type | Limited Company (ltd.) |
| Legal Entity State | ISRAEL |
Documents
Drawing
TEAS RF New ApplicationDesign Search Codes
| 05.03.25 | Leaf, single; Other leaves |
| 26.01.06 | Circles, semi; Semi |
| 26.01.13 | Circles, two (not concentric); Two circles |
| 26.01.16 | Circles touching or intersecting |
| 26.09.02 | Plain single line squares; Squares, plain single line |
| 27.03.04 | Plants forming letters or numerals |
| 050308 | More than one leaf, including scattered leaves, bunches of leaves not attached to branches |
| 050325 | Leaf, single; Other leaves |
| 260106 | Circles, semi; Semi |
| 260113 | Circles, two (not concentric); Two circles |
| 260116 | Circles touching or intersecting |
| 260902 | Plain single line squares; Squares, plain single line |
| 270304 | Plants forming letters or numerals |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | The color(s) dark green, light green, white and gray is/are claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-08-22 | |
| EXTENSION 5 GRANTED | 2020-08-21 | 66230 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-08-18 | 66230 |
| TEAS EXTENSION RECEIVED | 2020-08-13 | |
| EXTENSION 5 FILED | 2020-08-13 | 66230 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-02-29 | |
| TEAS EXTENSION RECEIVED | 2020-02-19 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-02-19 | |
| EXTENSION 4 GRANTED | 2020-02-19 | 98765 |
| EXTENSION 4 FILED | 2020-02-19 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-08-15 | |
| TEAS EXTENSION RECEIVED | 2019-08-13 | |
| EXTENSION 3 GRANTED | 2019-08-13 | 98765 |
| EXTENSION 3 FILED | 2019-08-13 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-02-15 | |
| TEAS EXTENSION RECEIVED | 2019-02-13 | |
| EXTENSION 2 GRANTED | 2019-02-13 | 98765 |
| EXTENSION 2 FILED | 2019-02-13 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-08-15 | |
| TEAS EXTENSION RECEIVED | 2018-08-13 | |
| EXTENSION 1 GRANTED | 2018-08-13 | 98765 |
| EXTENSION 1 FILED | 2018-08-13 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-02-20 | |
| PUBLISHED FOR OPPOSITION | 2017-12-26 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-12-26 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-12-06 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-11-17 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2017-11-17 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2017-11-17 | 67971 |
| EXAMINER'S AMENDMENT ENTERED | 2017-11-17 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-11-17 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-11-14 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-11-14 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-11-14 | 88889 |
| PRIORITY ACTION WRITTEN | 2017-05-26 | 67971 |
| PRIORITY ACTION E-MAILED | 2017-05-26 | 6326 |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2017-05-26 | 6326 |
| ASSIGNED TO EXAMINER | 2017-05-23 | 67971 |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2017-03-08 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-03-07 | |
| NEW APPLICATION ENTERED IN TRAM | 2017-03-03 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 